Contact

Bionaturis buys Zip Solutions from Inveready


, ,
Integral service around a transaction
BY : Diego GutiérrezMay Mon, 2016
The Bionaturis Group continues its growth process through acquisitions and has decided to acquire Zip, specialised in the development of technologies for the production of peptides and recombinant proteins with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors.

new funds

Located in the Research Park of the Universitat Autònoma de Barcelona, Zip has a team of three people and a portfolio of seven patent families. The company markets its proprietary Zera® and Splittera® tools, which facilitate the production and purification of difficult-to-express biological compounds and enhance the production capacity of cellular systems.

ZIP was founded in March 2015 as heir to the assets of Era Biotech, created in 2002 as a spin-off from the CSIC and in which around 13 million euros were invested. The company currently has seven patent families and is valued at 1.6 million euros.

The acquisition, in addition to extending the portfolio of Bionaturiswill help it to position itself in the international market as a reference partner for the development of biological products for human and animal health. Moreover, the entry of the Inveready fund in the parent company's shareholding is a positive point, due to the number of synergies that can be established both from a financial and industrial point of view.

La adquisición se ha realizado en la modalidad de compensación de créditos en el marco de una capital increase no dineraria.Como resultado de la transacción, valorada en 1,6 millones de euros, el fondo Inveready Biotech II entra a formar parte del accionariado de Bionaturis con una participación superior al 5%.

About the Bionaturis Group

The Bionaturis Group offers state-of-the-art biotechnological products and services for human and animal health.

Bionaturis, which is listed on the MAB, has already made several acquisitions in the past.

In 2014 Bionaturis acquired the company BBD BIOPHENIX S.L. (BBD), a company specialised in advanced drug screening systems, located in San Sebastian. Buy BBD BioPhenix has allowed it to increase its portfolio of clients in Europe and the United States, but also to attract new talent to become part of its global project.

In June 2015 it increased capital to finance and undertake the new inorganic growth and international expansion plan.
Other posts that may interest you

Ysios capital participates in $68M round in Kala pharmaceuticals

Inveready bets on biotechnology, invests in Cuantum and AB-biotics in less than a month

Investors lose their fear of investing in biotechnology

The M&A Professionals

Meet our services

MEET
OUR
METODOLOGY

Do you want to be up to date?

SUSCRIBE OUR NEWSLETTER

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu